Home 2018
Yearly Archives: 2018
FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer
First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer
FDA Approves First Blood Test to Evaluate Potential Concussions
Should help reduce unnecessary CT testing and associated radiation exposure
Poor Outcomes With Systolic BP Below 120 mm Hg in HFpEF
Increased risk of heart failure readmission at 30 days; of mortality, combined end point at 30 days, one year
Stress Reduction May Help Reduce Epileptic Seizures
Both focused attention and progressive muscle relaxation techniques cut seizures
Nusinersen Beneficial in Later-Onset Spinal Muscular Atrophy
Significant improvement in motor function compared with sham procedure among children with SMA
New Model Stratifies Patients With Long Bone Metastases
Model includes four prognostic categories with clinical consequences to predict median survival
Kidney Stone Incidence Increased Between 1984 and 2012
The increase included both symptomatic and asymptomatic kidney stones
GI Surgical Site Infections Higher in Low-Income Countries
Infection risk highest in countries with low income, low Human Development Index
Low Dose-Rate Far-UVC Light Can Inactivate Influenza Virus
Far-UVC at 222-nm light can inactivate aerosolized viruses; >95 percent of H1N1 influenza inactivated
Higher Biopsy Rates for Women Undergoing Screening Breast MRI
Lower cancer yield compared to mammography alone for women with, without personal history of cancer
